Background {#Sec1}
==========

Actinomycosis is an unusual sub-acute or chronic suppurative and granulomatous bacterial infection characterized by multiple abscesses, tissue fibrosis, and the formation of sinuses and fistulae \[[@CR1]\]. The culprits ensuing the infection, *Actinomyces* spp., are the aerobic or micro-aerophilic filamentous gram-positive bacilli which basically colonized in oropharynx, gastrointestinal tract and uro-genital tract \[[@CR1]--[@CR3]\]. Despite, the indigenous habitat of the pathogen, a few cases of actinomycosis inflicting bone and joints, skin and soft tissue, CNS, respiratory tract, digestive tract can be found on a literature search \[[@CR1], [@CR3]\]. Of reported clinical manifestations, disseminated forms, originating from other colonized sites, are likely occurring; however, primary actinomycosis involving only principle site i.e. extremities is extremely rare \[[@CR3]--[@CR5]\].

It is somewhat surprising, the reported incidence of actinomycosis in PLHA has remained low; nevertheless, the persistent impairment in both cellular and humoral immunity are more obvious, due to HIV (human immunodeficiency virus) \[[@CR6]\]. The reason for this is not clear, nonetheless, can be speculated due to misdiagnosis. The misdiagnosis often occurs, particularly in PLHA where myriads of other infections are more common, owing to similar indolent and non-specific clinical manifestations of actinomycosis which masquerades as infections of other etiologies \[[@CR6], [@CR7]\]. With this backdrop, herein, we report a case of primary cutaneous actinomycosis, mimicking as cutaneous tuberculosis, in a patient living with HIV/AIDS.

Case presentation {#Sec2}
=================

A 42-year-old farmer presented to the Dermatology out-patient department (OPD), Sumeru Hospital, a tertiary care hospital in Kathmandu, with the complaint of a large hard lesion that with time multiplied gradually and had multiple openings discharging pus. He had lived with HIV for 6 years and was from middle-class socio-economic status. Besides, no previous history of systemic illness and major surgical interventions was described. Although, he reported being bitten by own dog earlier 1 month ago on same foot, before the lesion first appears. Based upon the clinical presentations and unresolved lesion with extended courses of antimicrobial therapy (cloxacillin), the previous diagnosis was made as cutaneous tuberculosis, from the local hospital; was treated with anti-tubercular treatment (ATT) for 4 months. Inconsistently, the lesions continued to progress with pus and bloody discharges. On clinical examination, the patient had a large plaque-like lesion about 10 cm × 6 cm overlying skin with papules and nodules on the dorsum of a left leg (Fig. [1](#Fig1){ref-type="fig"}). Over the lesion, multiple discharging sinuses draining sero-sanguinous fluid were scattered. No other lesion elsewhere on the body was observed, however. His neurovascular status of the foot was normal with no associated regional lymphadenopathy. Scrutinizing these clinical presentations and clinical history, the differential diagnosis of rifampicin-resistant cutaneous tuberculosis, mycetoma/madura foot, and cutaneous nocardiosis was made.Fig. 1Large plaque-like lesion about 10 cm × 6 cm with papules and nodules; multiple discharging sinuses draining sero-sanguinous fluid

Investigation {#Sec3}
=============

Histopathological examination, of stabbed biopsy, revealed hyper-keratosis and mild-acanthosis of the epidermis, while acute inflammatory infiltrates comprising plasma cell, macrophages and neutrophils were observed in the upper and mid dermis. Peripheral blood smear portrayed normal cell morphology, normal hemoglobin level (13 gm/dL); while, WBC (12,400/mL) and platelets (4, 15,200/µL) count were slightly elevated. Serological test for HBsAg and HCV were non-reactive; although, HIV was positive (ELISA) with drop off CD4 count 128 cell/µL.

The presumptive identification of etiologies was done with gram staining from the lesion which revealed branching filamentous gram-positive bacteria suggestive *Actinomyces* spp. (Fig. [2](#Fig2){ref-type="fig"}). As of further microbiological approaches, the cultured pus aspirate grew molar tooth shaped adherent colonies after 72 h of incubation at 36 °C on blood agar and chocolate agar in presence of ambient air, 5% Co~2~ (Figs. [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}). Since molecular analysis and sequencing was not accessible in our laboratory setting; further, identification of the isolate, *Actinomyces israeli*, was done with standard microbiological culture methods as recommended by American Society for Microbiology based upon phenotypic characteristics and biochemical interpretations \[[@CR8]\]. In brief, colony morphology (chalky, matt, dry, crumbly, adherent in appearances; 0.5--2.0 mm in diameter with fine intertwining, branching filaments); in-house set of biochemical test: pigmentation (negative), catalase (negative), nitrate reduction (positive), hydrolysis of urea (negative) while esculin (positive), production of α-glucosidase and β-galactosidase (positive) while α-fucosidase and β-NAG (negative), fermentation of arabinose, maltose, raffinose, rhamnose, sucrose, xylose, trehalose (positive) while mannitol (negative). The antimicrobial susceptibility testing was done by modified Kirby-baur disc diffusion method on blood agar against commercially prepared antibiotic disks (Hi-Media Laboratories, Pvt, limited, India) in compliance with Clinical Laboratory Standards Institute (CLSI). The isolate was sensitive to penicillin G, amoxicillin, ceftriaxone, meropenem, doxycycline, linezolid, clindamycin, while ciprofloxacin and erythromycin were found resistant. Gene Xpert testing from the pus sample was negative for *Mycobacterium tuberculosis* with no associated resistant gene. No fungal elements grew from the pus aspirate; blood and urine sample were sterile.Fig. 2Gram stain: gram positive branching filamentous bacteria suggestive *Actinomyces* spp. (×1000 orginal magnification) Fig. 3Colonial morphology of *Actinomyces israelii* on blood agar: whitish chalky adherent colonies with molar tooth appearance Fig. 4Colonial morphology of *Actinomyces israelii* on chocolate agar: whitish chalky adherent colonies with molar tooth appearance

Additionally, CT scan of abdomen and chest was done to rule-out possible disseminated actinomycosis; conversely, no abnormalities detected. In view of clinical manifestations and investigation reports, a diagnosis of primary cutaneous actinomycosis was made in HIV positive patient. After then, anti-tubercular therapy was discontinued and the patient was treated with intravenous benzylpenicillin (Penicillin G) for 6 weeks followed by oral phenoxymethylpenicillin (Penicillin V) for another 6 weeks.

Treatment {#Sec4}
=========

The patient was treated with penicillin G--24 million U/d intravenous by continuous infusion for 6 weeks; and then shifted to oral penicillin V for another 6 weeks then to follow. The oral penicillin was continued up to 12 months.

Outcomes and follow-up {#Sec5}
======================

He has now completed 3 months of antimicrobial therapy; has undergone progressive changes---flattening and regression of the indurated lesion observed---no sign of relapse noted (Fig. [5](#Fig5){ref-type="fig"}). The oral penicillin V continued for a year to limit the possible late relapse. Now, the lesion healed completely without recur.Fig. 5Flattening and regression of the indurated lesion after 3 months of antimicrobial therapy (Penicillin)

Literature search {#Sec6}
=================

All the relevant information presented in table and literature review included in the manuscript was collected via searching Google, Pub Med/NCBI and other similar databases from 1986 to 2017. Key search terms were actinomycosis, HIV/AIDS, diagnosis consideration and clinical management (Table [1](#Tab1){ref-type="table"}) \[[@CR9]--[@CR25]\].Table 1Summary of actinomycosis and its clinical management in patient living with HIV/AIDS patient, reported in English-language literatureS. noReferencesCD4 count/µLSurgical interventionAntimicrobial therapyTreatment durationOutcomesCervicofacial actinomycosis1Yeager et al. \[[@CR9]\]NANot donePenicillin G (IV) + oral penicillinPenicillin-G = 6 weeks; oral penicillin = 3 monthsCured2Watkins et al. \[[@CR10]\]NAEdematous soft tissue and sequestrum were removedPenicillin G (IV)6 weeksCured3Manfredi et al. \[[@CR11]\]case 1(11); case 2(4)Surgical debridement of tissueItraconazole + ceftazidime + netilmicinFew weeksDied4Kingdom et al. \[[@CR12]\]499Not doneOral penicillin3 monthsCured5Manfredi et al. \[[@CR13]\](case 1)9Surgical debridement of tissueFluconazole. Ceftriaxone, netilmicin, itraconazole and ceftazidimeFew daysDied(case 2)2Surgical debridement of tissueFluconazole, ceftriaxone, netilmicin, itraconazole, piperacillin and clindamycin45 daysDied6Vazquez et al. \[[@CR14]\]480Surgical incision of the tissueOral amoxycillin3 weeksCured7Spadari et al. \[[@CR15]\]NANot doneOral doxycycline (patient was penicillin allergic)2 monthsDied8Yuria et al. \[[@CR16]\]63Not doneIntravenous ampicillin2 weeksCured9Sudhakar et al. \[[@CR17]\]82Not doneAmpicillin salbactam (IV) + amoxycillin--clavulanic acidAmpicillin salbactam (IV) = 4 days; amoxycillin--clavulanic acid = 5 daysCured10Klein et al. \[[@CR18]\]367Removed maxillary bone sequestrationPenicillin G (IV) + amoxycillinPenicillin G (IV) = 3 weeks; oral amoxicillin = 6 monthsCuredThoracic actinomycosis11Cendan et al. \[[@CR19]\]NANot donePenicillin G4 weeksDiedPulmonary actinomycosis12Tabarsi et al. \[[@CR20]\]NAUpper lobectomyOral penicillin; clindamycin, metronidazole, trimethoprim/sulfamethoxazole (TMP--SMX) and ceftriaxone were added to Highly Active Antiretroviral Therapy (HAART)6 monthsCuredGastro interstinal actinomycosis 13Spencer et al. \[[@CR21]\]NANot doneAntacids and ketoconazoleNot describedCured14Litt et al. \[[@CR22]\]100Not doneOral penicillin5 monthsCured15Arora et al. \[[@CR23]\]4Not doneIntravenous penicillin + fluconazole4 weeksDied with other cause16Redelman et al. \[[@CR24]\]22Not doneDoxycycline (IV) (the patient was allergic to penicillin)4 monthsDied with other causePrimary cutaneous actinomycosis (lower extermities)17Gomes et al. \[[@CR25]\]123Wound debridementTrimethoprim + sulfomethoxazole + ART (emtricitabina + tenofovir, ritonavir, and darunavir)4 monthsCured*ART* antiretroviral therapy, *IV* intra-venous, *HAART* highly active antiretroviral therapy, *TMP--SMX* trimethoprim/sulfamethoxazole

Discussion {#Sec7}
==========

The emergence of HIV and the onset of AIDS epidemic have been associated with a myriad of opportunistic cutaneous infections; however, the cutaneous actinomycosis is out-of-the limelight from the differential diagnosis. The masquerading clinical presentations as cutaneous tuberculosis, fungal infections, malignancies and other systemic infections, difficult in vitro cultivation of the pathogen, and non-specific radiological picture are commonly associated outfits leading misdiagnosis \[[@CR6]\]. In our case, the primordial diagnosis was made as cutaneous tuberculosis, based upon the clinical presentations and unresolved lesion with extended courses of antimicrobial therapy (cloxacillin). Further, unresolved lesion, even after the anti-tubercular therapy implies a differential diagnosis of rifampicin-resistant cutaneous tuberculosis, mycetoma/madura foot, and cutaneous nocardiosis.

Relating the endogenous habitat or colonization of the pathogen, *Actinomyces israelii*, the primary cutaneous actinomycosis of a lower extremity is extremely rare; associated either with post-traumatic exposure or direct implantation of the pathogen via animal, insects or human bites \[[@CR26]--[@CR28]\]. Linking the common ground of infection acquisition, probably the pathogen could have inoculated from the dog bites since no other clinical history suggesting sourced pathogen reported. No detectable extra-cutaneous lesions and radiological picture portentous to the dissemination were observed.

Moreover, difficulties in in vitro cultivation of the pathogen attribute further diagnostic challenges; since, longer incubation, up to 10 days, is obligatory prior to be reported as sterile \[[@CR3], [@CR29]\]. Earlier, the presumptive diagnosis could have made at least with gram staining in the local hospital; despite, relying only upon clinical manifestations; which inturn could prevent the erroneous diagnosis and treatment. Needless to say, but it is the ground reality of clinical practice, in developing countries like Nepal. The identification of the etiology, *Actinomyces israelii*, was done by standard microbiological culture methods as recommended by the American Society for Microbiology based upon: phenotypic characteristics of the isolate, its antimicrobial susceptibility pattern against antibiotics, extended incubation period and biochemical interpretations; sequencing of 16SrRNA, however, was not available in our setting \[[@CR8], [@CR29], [@CR30]\]. Therefore, prior to starting the antimicrobial therapy, a high index of clinical suspicion together with close collaboration with microbiological interpretations is of utmost importance, for successful outcomes.

For successful management and treatment in cutaneous actinomycosis---limiting possible late relapse: early detection of the pathogen, recommended surgical debridement along with the appropriate selection of antimicrobial therapy, correct dosing, and treatment duration; are crucial \[[@CR31], [@CR32]\]. High-dose of penicillin over a prolonged period, 6 months to 1 year, is presumed as the drug of choice for all forms of actinomycosis \[[@CR1], [@CR6], [@CR17], [@CR27], [@CR32]\]. As an alternative to penicillin, if the patient is hypersensitive to penicillin or if etiologies are resistant to penicillin, the antibiotics such as clindamycin, erythromycin, tetracycline, doxycycline, ceftriaxone, and chloramphenicol could be opted \[[@CR32]--[@CR34]\]. However, the clinicians must be cautious while opting the antibiotics: metronidazole, aminoglycosides, aztreonam, co-trimoxazole (TMP--SMX), penicillinase-resistant penicillins (e.g., methicillin, nafcillin, oxacillin, cloxacillin), and cephalexin, since these antibiotics possess nearly no activity against *Actinomyces* spp. \[[@CR33].\]. Unfolding to our case, no progressive changes on the lesion occurred; since as implicated antibiotic therapy i.e. cloxacillin was opted, initially. Although, on shifting to penicillin the patient undergone progressive changes; lesion healed subsequently and no relapse noted. Therefore, it is mandatory that the therapeutic regimen should be customized for each patient depending upon the susceptibility of the pathogen against the antibiotics.

The adverse reaction, nevertheless, owing to prolonged and high dose of penicillin therapy, are common including pseudomembranous colitis, interstitial nephritis, epigastric distress, urticarial, leukopenia, allergic reactions, eosinophilia, and super-infection \[[@CR35]\]. No such side effects were found to be associated in our case, however. The patient reported a few episodes of nausea, vomiting, and diarrhea during 12 months of medication as minimal side effects.

Conclusion {#Sec8}
==========

In clinical practice, the cutaneous actinomycosis often outfits with diagnostic challenges, owing to the multifaceted clinic-pathological features as of cutaneous infection with different etiology, and inherent difficulty in in vitro cultivating. Therefore, cutaneous actinomycosis requires a diagnosis consideration, especially in PLHA, where myriad of opportunistic cutaneous infections are common.
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